Cabergoline Online

How and where to order Cabergoline (Dostinex, Cabaser, Cabgolin) 0.25 mg, 0.5 mg, 1 mg tablets online on the International Consumer Support for Infertility website:

Shop:	DFH PHARMACY - 10% discount coupon DFH10
Sellers:	CABERGOLINE STORES
Prices:	from $2.90 per pill
Forms:	0.25 mg, 0.5 mg, 1 mg tablets
Quantity:	4-90 pills
Type:	Cabaser brand, Cabgolin brand, Dostinex brand and generics
Payment:	Visa, Mastercard, AmEx, Bitcoin
Delivery:	Regular and express mail service
Shipping:	Worldwide, including USA, UK, Europe, Canada, Australia

Indications and usage:

Cabergoline tablets are indicated for the treatment of:

hyperprolactinemia, hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas (including amenorrhea, oligomenorrhea, galactorrhea, anovulation, nonpuerperal mastitis)

high levels of prolactin which occur with certain tumors such as prolactinoma, uterine fibroids

other disorders due to high levels of prolactin, a hormone made by the body that affects such things as the menstrual cycle, breast milk production, fertility, sexual function

Parkinson's disease

acromegaly

lactation suppression

ablactation

restless-legs syndrome

as an adjunct to SSRI antidepressants

for recreational purposes in reducing or eliminating the male refractory period

in veterinary medicine for gods, cats, and other animals

Dosage and administration:

The recommended dosage of Dostinex (Cabergoline) tablets for initiation of therapy is 0.25 mg twice a week. Dosage may be increased by 0.25 mg twice weekly up to a dosage of 1 mg twice a week according to the patient's serum prolactin level. Before initiating treatment, cardiovascular evaluation should be performed and echocardiography should be considered to assess for valvular disease.

Dosage increases should not occur more rapidly than every 4 weeks, so that the physician can assess the patient's response to each dosage level. If the patient does not respond adequately, and no additional benefit is observed with higher doses, the lowest dose that achieved maximal response should be used and other therapeutic approaches considered. Patients receiving long term treatment with Dostinex should undergo periodic assessment of their cardiac status and echocardiography should be considered.

After a normal serum prolactin level has been maintained for 6 months, cabergoline may be discontinued, with periodic monitoring of the serum prolactin level to determine whether or when treatment with this medication should be reinstituted. The durability of efficacy beyond 24 months of therapy with Cabergoline (Dostinex) has not been established

Overdosage:

Overdosage by cabergoline might be expected to produce nasal congestion, syncope, or hallucinations. Measures to support blood pressure should be taken if necessary.

Dosage forms and strengths:

Dostinex (Cabergoline) tablets are white, scored, capsule-shaped tablets containing 0.5 mg cabergoline. Each tablet is scored on one side and has the letter P and the letter U on either side of the breakline. The other side of the tablet is engraved with the number 700.

Cabgolin (Cabergoline) tablets 0.25 mg, 0.5 mg.

Cabaser (Cabergoline) tablets 0.25 mg, 1 mg, 2 mg, 4 mg.

Contraindications:

Cabergoline (Dostinex) tablets are contraindicated in patients with:

Uncontrolled hypertension or known hypersensitivity to ergot derivatives.

History of cardiac valvular disorders, as suggested by anatomical evidence of valvulopathy of any valve, determined by pre-treatment evaluation including echocardiographic demonstration of valve leaflet thickening, valve restriction, or mixed valve restriction-stenosis.

History of pulmonary, pericardial, or retroperitoneal fibrotic disorders.

Warnings and precautions:

Pregnancy: dopamine agonists in general should not be used in patients with pregnancy-induced hypertension, for example, preeclampsia, eclampsia, and post partum hypertension, unless the potential benefit is judged to outweigh the possible risk.

Cardiac valvulopathy: all patients should undergo a cardiovascular evaluation, including echocardiogram to assess the potential presence of valvular disease.

Extracardiac fibrotic reactions: postmarketing cases of pleural, pericardial, and retroperitoneal fibrosis have been reported following administration of Dostinex.

Initial doses higher than 1.0 mg may produce orthostatic hypotension. Care should be exercised when administering cabergoline with other medications known to lower blood pressure.

Postpartum lactation inhibition or suppression: this medication is not indicated for the inhibition or suppression of physiologic lactation. Use of bromocriptine, another dopamine agonist for this purpose, has been associated with cases of hypertension, stroke, and seizures.

Hepatic impairment: since cabergoline is extensively metabolized by the liver, caution should be used, and careful monitoring exercised, when administering Dostinex to patients with hepatic impairment.

Psychiatric: impulse control/compulsive behaviors, including pathological gambling, increased libido, and hypersexuality have been reported in patients treated with dopamine agonists including cabergoline.

Adverse reactions, side effects:

The most frequently reported adverse experiences with cabergoline tablets have been abnormal or unusual thoughts, heart valve and related disorders e.g. inflammation (pericarditis) or leaking of fluid in the pericardium (pericardial effusion), development of a widespread itchy rash, difficulty breathing with or without wheezing, feeling faint, unexplained swelling of the body or tongue or any other symptoms which appear to come on rapidly after taking this medication and make you feel unwell.

To report suspected side effects of Dostinex (Cabergoline) tablets contact Pfizer pharmaceutical company or your local FDA.

Drug interactions:

Some medication can reduce the effectiveness of cabergoline, these include:

drugs used to treat mental illness (e.g. antipsychotic medicines like chlorpromazine, haloperidol)

medicines for nausea and vomiting (e.g. domperidone, metoclopramide)

Some medication can increase the amount of cabergoline in your blood and so could increase the side effects, these include:

medicines for Parkinson's disease

drugs for severe migraine headaches (e.g. pergolide, bromocriptine, lisuride, ergotamine, dihydroergotamine, ergometrine or methysergide)

antibiotics (e.g. erythromycin)

Related medications:

Female Viagra

Letrozole for fertility

Use in specific populations:

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Dostinex should be used during pregnancy only if clearly needed.

Nursing mothers

It is not known whether cabergoline is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from this medication, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Use of Dostinex for the inhibition or suppression of physiologic lactation is not recommended.

The prolactin-lowering action of cabergoline suggests that it will interfere with lactation. Due to this interference with lactation, this drug should not be given to women postpartum who are breastfeeding or who are planning to breastfeed.

Pediatric use

Safety and effectiveness of Cabergoline (Dostinex, Cabaser, Cabgolin) tablets in pediatric patients have not been established.

Geriatric use

Clinical studies of this medication did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Information for patients:

Patients should be instructed to notify their physician if they suspect they are pregnant, become pregnant, or intend to become pregnant during therapy. A pregnancy test should be done if there is any suspicion of pregnancy and continuation of treatment should be discussed with their physician.

Patients should notify their physician if they develop shortness of breath, persistent cough, difficulty with breathing when lying down, or swelling in their extremities.

Patients should be alerted to the possibility that patients may experience intense urges to spend money uncontrollably, intense urges to gamble, increased sexual urges, and other intense urges and the inability to control these urges while taking cabergoline. Advise patients to inform their healthcare provider if they develop new or increased uncontrolled spending, gambling urges, sexual urges, or other urges while being treated with Dostinex pills.

Where to buy cabergoline online:

To purchase Dostinex, Cabaser, Cabgolin (Cabergoline) 0.25 mg, 0.5 mg, 1 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.

Here is a list of popular medications containing cabergoline as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

Trade name of the drug	Pharmaceutical forms and doses	Companies
Cabaser	Tablets; Oral; Cabergoline 0.25 mg, 1 mg, 2 mg, 4 mg	Pfizer O.P.D. Laboratories Perrigo Primecrown
Cabergolina	Tablets; Oral; Cabergoline 0.5 mg	Teva
Cabgolin	Tablets; Oral; Cabergoline 0.25 mg, 0.5 mg	Sun Pharmaceutical Industries
Dostinex	Tablets; Oral; Cabergoline 0.5 mg	Pfizer Euro Registratie Kenfarma Lenis Farmacevtika O.P.D. Laboratories Paladin Laboratories Perrigo Primal Chemical Primecrown Zuellig Pharma
Sostilar	Tablets; Oral; Cabergoline 0.5 mg	Pfizer